(Q33855883)

29 July 2017

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody (English)

1 reference

29 July 2017

1 reference

Kuwana M

1

1 reference

29 July 2017

Kaburaki J

2

1 reference

29 July 2017

Arnett FC

3

1 reference

29 July 2017

Howard RF

4

1 reference

29 July 2017

Medsger TA Jr

5

1 reference

29 July 2017

Wright TM

6

1 reference

29 July 2017

language of work or name

1 reference

1 March 1999

1 reference

29 July 2017

Arthritis & Rheumatology

1 reference

29 July 2017

42

1 reference

29 July 2017

3

1 reference

29 July 2017

465-474

1 reference

HLA and autoimmunity in scleroderma (systemic sclerosis).

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Occupational and environmental influences on scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Serological markers in progressive systemic sclerosis: clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Severe restrictive lung disease in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

The effect of D-penicillamine on pulmonary findings in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Epidemiology of Systemic Sclerosis (Scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Racial differences in the frequencies of scleroderma-related autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Major histocompatibility complex class II gene associations with anti-U1 small nuclear ribonucleoprotein antibody. Relationship to immunoreactivity with individual constituent proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Clinical correlations with HLA type in Japanese patients with connective tissue disease and anti-U1 small nuclear RNP antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Familial clustering of scleroderma spectrum disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Systemic sclerosis secondary to occupational exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

21 January 2018

Scleroderma epidemiology

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Autoantibody reactive with RNA polymerase III in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Autoantigenic epitopes on DNA topoisomerase I. Clinical and immunogenetic associations in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Pulmonary involvement in systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Serial pulmonary function in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Severe systemic sclerosis with anti-topoisomerase I Antibodies is associated with an HLA-DRw11 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199904%2942%3A3%3C465%3A%3AAID-ANR11%3E3.0.CO%3B2-Y

10.1002/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference